Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06515093 · ClinicalTrials.gov registry record · NA
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
A NA study of Diabetic Foot Ulcer and Venous Leg Ulcer, sponsored by Surgenex.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 2
- Study locations
NCT06515093 is a NA study of Diabetic Foot Ulcer and Venous Leg Ulcer that is actively recruiting participants, run by Surgenex. The registered enrollment target is 180 participants, below the 252-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (29% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06515093, a NA study of Diabetic Foot Ulcer and Venous Leg Ulcer, is actively recruiting participants, sponsored by Surgenex.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to compare Pellograft to standard of care modalities in treating diabetic foot ulcers in human subjects, and to compare Sanograft to standard of care in treating venous leg ulcers. The study will demonstrate wound healing outcomes with comparators including time to wound epithelialization, decrease in wound size, and total number of study product applications towards healing outcome. This information is important to the Centers for Medicare and Medicaid Services (CMS) and other payors in determining coverage policy and reimbursement for this product category.
Conditions Studied
Interventions
- OTHER PelloGraft
- OTHER SanoGraft
Study Locations (2)
California
- ILD Research - Vista
Oklahoma
- Tulsa Wound Center - Tulsa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2024-06-23 |
| Est. Completion | 2026-09-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06515093
The ClinicalTrials.gov registry entry for NCT06515093 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 252-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (29% lower). The listed sponsor is Surgenex, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 2 interventions - of which PelloGraft is the first listed.
NCT06515093 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Oklahoma.
Frequently Asked Questions
What is clinical trial NCT06515093 about?
NCT06515093 is a clinical study titled "Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC". The purpose of this study is to compare Pellograft to standard of care modalities in treating diabetic foot ulcers in human subjects, and to compare Sanograft to standard of care in treating venous leg ulcers. The study will demonstrate wound healing outcomes with comparators including time to wound...
What is the current status of trial NCT06515093?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2024-06-23. Estimated completion is 2026-09-09.
What conditions does trial NCT06515093 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Venous Leg Ulcer.
What interventions are being tested in trial NCT06515093?
The interventions under investigation include: PelloGraft (OTHER), SanoGraft (OTHER).
Who is sponsoring clinical trial NCT06515093?
This trial is sponsored by Surgenex, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06515093 being conducted?
This trial has 2 study locations across California, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
-
Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.